| Financial Year |
March 31 2023 |
| Monetary Funds |
2,616,444,000.00 |
| Held-for-trading Financial Assets |
7,778,411,200.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
6,100,664,700.00 |
| Advances to Suppliers |
820,657,200.00 |
| Other Receivables |
22,844,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,386,915,400.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,628,653,300.00 |
| Other Current Assets |
256,481,100.00 |
| Total Current Assets |
25,633,736,700.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
13,346,634,500.00 |
| Under-construction Projects |
294,109,400.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,247,510,900.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
205,148,700.00 |
| Deferred Income Tax Assets |
240,208,700.00 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
16,449,793,700.00 |
| Total Assets |
42,083,530,400.00 |
| Short-Term Loans |
389,692,400.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
97,785,100.00 |
| Accounts Payable |
11,347,901,400.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
344,747,600.00 |
| Taxes Payable |
144,604,700.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
543,854,500.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
91,961,700.00 |
| Other Current Liabilities |
586,504,300.00 |
| Sub-Total of Current Liabilities |
15,239,227,300.00 |
| Long-term Loans |
158,719,800.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
260,748,900.00 |
| Deferred Income Tax Liabilities |
104,207,400.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
696,304,900.00 |
| Total Liabilities |
15,935,532,200.00 |
| Paid-In Capital(Or Share Stock) |
4,421,354,800.00 |
| Capital Surplus |
4,248,021,700.00 |
| Surplus Reserve |
1,937,612,800.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,359,025,800.00 |
| Minority Stockholder's Interest |
1,981,987,300.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,166,010,900.00 |
| Owner's Equity（Stockholder's Equity） |
26,147,998,200.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
42,083,530,400.00 |
